These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33839143)

  • 21. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
    Lai JH; Chen KY; Wu JC; Olson L; Brené S; Huang CZ; Chen YH; Kang SJ; Ma KH; Hoffer BJ; Hsieh TH; Chiang YH
    Brain Res; 2019 Oct; 1720():146301. PubMed ID: 31226324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease.
    Rial D; Castro AA; Machado N; Garção P; Gonçalves FQ; Silva HB; Tomé AR; Köfalvi A; Corti O; Raisman-Vozari R; Cunha RA; Prediger RD
    PLoS One; 2014; 9(12):e114216. PubMed ID: 25486126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson's Disease.
    Sierra-Magro A; Bartolome F; Lozano-Muñoz D; Alarcón-Gil J; Gine E; Sanz-SanCristobal M; Alonso-Gil S; Cortes-Canteli M; Carro E; Pérez-Castillo A; Morales-García JA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.
    Ghaisas S; Langley MR; Palanisamy BN; Dutta S; Narayanaswamy K; Plummer PJ; Sarkar S; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Neurotoxicology; 2019 Dec; 75():186-199. PubMed ID: 31505196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Song B; Feldmann JW; Cao S; Feitosa M; Kong Y; Kim W; Schweitzer A; Leblanc P; Schweitzer JS; Kim KS
    Neurobiol Dis; 2022 Aug; 170():105777. PubMed ID: 35636646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functions.
    Song S; Wang Q; Jiang L; Oyarzabal E; Riddick NV; Wilson B; Moy SS; Shih YI; Hong JS
    Brain Behav Immun; 2019 Oct; 81():374-387. PubMed ID: 31247288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MitoPark mice, an animal model of Parkinson's disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A(2A) antagonist SCH 412348.
    Grauer SM; Hodgson R; Hyde LA
    Psychopharmacology (Berl); 2014 Apr; 231(7):1325-37. PubMed ID: 24150248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.
    Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J
    PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson's disease.
    Ay M; Charli A; Langley M; Jang A; Padhi P; Jin H; Anantharam V; Kalyanaraman B; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2024; 18():1356703. PubMed ID: 38449738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Mitochondrial Dysfunction on Dopaminergic Neurons in the Olfactory Bulb and Odor Detection.
    Paß T; Aßfalg M; Tolve M; Blaess S; Rothermel M; Wiesner RJ; Ricke KM
    Mol Neurobiol; 2020 Sep; 57(9):3646-3657. PubMed ID: 32564285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial dysfunction-induced H3K27 hyperacetylation perturbs enhancers in Parkinson's disease.
    Huang M; Lou D; Charli A; Kong D; Jin H; Zenitsky G; Anantharam V; Kanthasamy A; Wang Z; Kanthasamy AG
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34494552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.
    Tadaiesky MT; Dombrowski PA; Figueiredo CP; Cargnin-Ferreira E; Da Cunha C; Takahashi RN
    Neuroscience; 2008 Oct; 156(4):830-40. PubMed ID: 18817851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2.
    Casadei N; Sood P; Ulrich T; Fallier-Becker P; Kieper N; Helling S; May C; Glaab E; Chen J; Nuber S; Wolburg H; Marcus K; Rapaport D; Ott T; Riess O; Krüger R; Fitzgerald JC
    Hum Mol Genet; 2016 Feb; 25(3):459-71. PubMed ID: 26604148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.
    Moisoi N; Fedele V; Edwards J; Martins LM
    Neuropharmacology; 2014 Feb; 77():350-7. PubMed ID: 24161480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease.
    Farrand AQ; Gregory RA; Bäckman CM; Helke KL; Boger HA
    Brain Res; 2016 Nov; 1651():88-94. PubMed ID: 27659966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling.
    Hong CT; Chen KY; Wang W; Chiu JY; Wu D; Chao TY; Hu CJ; Chau KD; Bamodu OA
    Cells; 2020 Mar; 9(3):. PubMed ID: 32192190
    [No Abstract]   [Full Text] [Related]  

  • 39. MPP
    Cunha MP; Pazini FL; Lieberknecht V; Budni J; Oliveira Á; Rosa JM; Mancini G; Mazzardo L; Colla AR; Leite MC; Santos ARS; Martins DF; de Bem AF; Gonçalves CAS; Farina M; Rodrigues ALS
    Mol Neurobiol; 2017 Oct; 54(8):6356-6377. PubMed ID: 27722926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease.
    Prediger RD; Rojas-Mayorquin AE; Aguiar AS; Chevarin C; Mongeau R; Hamon M; Lanfumey L; Del Bel E; Muramatsu H; Courty J; Raisman-Vozari R
    J Neural Transm (Vienna); 2011 Aug; 118(8):1215-25. PubMed ID: 21301897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.